Free tool
Medicare drug spending
Last checked: Nov 20, 2026Latest source record: 2024 calendar yearSource: CMS (Medicare Part D Spending by Drug : 2024-01-01; Medicare Part B Spending by Drug : 2024-01-01)Methods & limitations
Part D, 2024
$288.7B
Gross drug spending in the dataset
Part B, 2024
$60.8B
Gross drug spending in the dataset
Drugs listed
17
Part D and Part B
Total spending by year
- Part D
- Part B
View as table
| Year | Part D | Part B |
|---|---|---|
| 2020 | $194,092,038,339 | $37,778,829,680 |
| 2021 | $213,513,349,361 | $40,135,340,775 |
| 2022 | $239,779,215,689 | $44,241,259,745 |
| 2023 | $275,808,918,753 | $50,775,853,083 |
| 2024 | $288,667,842,058 | $60,838,164,403 |
Top 17 by total spending
2024 figures. Growth compares with 2023. Per-beneficiary ranks skip drugs with fewer than 11 beneficiaries.
| Drug | Part | Spending | Change | Beneficiaries | Per beneficiary | Per unit |
|---|---|---|---|---|---|---|
| Norgestimate-Ethinyl Estradiol Norgestimate-Ethinyl Estradiol | D | $402K | -18% | 4,593 | $88 | $0.42 |
| Sprintec Norgestimate-Ethinyl Estradiol | D | $347K | -21% | 4,635 | $75 | $0.34 |
| Tri-Sprintec Norgestimate-Ethinyl Estradiol | D | $239K | -27% | 2,597 | $92 | $0.40 |
| Estarylla Norgestimate-Ethinyl Estradiol | D | $234K | -36% | 3,249 | $72 | $0.35 |
| Mili Norgestimate-Ethinyl Estradiol | D | $144K | -23% | 1,997 | $72 | $0.35 |
| Tri-Lo-Mili Norgestimate-Ethinyl Estradiol | D | $141K | -6% | 1,331 | $106 | $0.50 |
| Tri-Estarylla Norgestimate-Ethinyl Estradiol | D | $85K | -53% | 950 | $89 | $0.45 |
| Mono-Linyah Norgestimate-Ethinyl Estradiol | D | $78K | -6% | 977 | $80 | $0.41 |
| Tri-Lo-Marzia Norgestimate-Ethinyl Estradiol | D | $74K | +4% | 762 | $97 | $0.47 |
| Tri-Lo-Estarylla Norgestimate-Ethinyl Estradiol | D | $59K | +8% | 590 | $100 | $0.55 |
| Tri-Linyah Norgestimate-Ethinyl Estradiol | D | $49K | -41% | 515 | $96 | $0.42 |
| Tri-Mili Norgestimate-Ethinyl Estradiol | D | $42K | n/a | 549 | $77 | $0.42 |
| Prefest Estradiol/Norgestimate | D | $23K | -85% | 46 | $504 | $6.19 |
| Tri-Lo-Sprintec Norgestimate-Ethinyl Estradiol | D | $5K | -95% | 134 | $37 | $0.54 |
| Vylibra Norgestimate-Ethinyl Estradiol | D | $1K | -54% | 32 | $43 | $0.34 |
| Tri-Vylibra Lo Norgestimate-Ethinyl Estradiol | D | $1K | -42% | 31 | $42 | $0.34 |
| Tri-Vylibra Norgestimate-Ethinyl Estradiol | D | $1K | -52% | 20 | $52 | $0.30 |
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.